Bilal Arif
Chief Tech/Sci/R&D Officer bei SAREPTA THERAPEUTICS, INC.
Vermögen: 3 Mio $ am 31.03.2024
Profil
Bilal Arif is currently the Chief Technical Operations Officer & Executive VP at Sarepta Therapeutics, Inc. Previously, he worked as the Vice President-Technical Operations at Momenta Pharmaceuticals, Inc. from 2017 to 2019.
Mr. Arif completed his undergraduate degree at McGill University, his graduate degree at Tufts University, and his MBA at Instituto de Empresa SL.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
08.03.2024 | 25 222 ( 0,03% ) | 3 Mio $ | 31.03.2024 |
Aktive Positionen von Bilal Arif
Unternehmen | Position | Beginn |
---|---|---|
SAREPTA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 31.12.2022 |
Ehemalige bekannte Positionen von Bilal Arif
Unternehmen | Position | Ende |
---|---|---|
MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 02.01.2019 |
Ausbildung von Bilal Arif
McGill University | Undergraduate Degree |
Tufts University | Graduate Degree |
Instituto de Empresa SL | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SAREPTA THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |